A Response to the Letter to the Editor: "Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?"
Recommended Citation
Lam VK, and Gadgeel SM. A Response to the Letter to the Editor: “Can We Refine Criteria for the First-Line Treatment for Patients With Advanced ALK-Positive NSCLC in the Real World?”. J Thorac Oncol 2025; 20(6):e73.
Document Type
Article
Publication Date
6-1-2025
Publication Title
J Thorac Oncol
PubMed ID
40484493
Volume
20
Issue
6
First Page
73
Last Page
73
COinS
